Translation Elongation Factor eEF1A2 is a Novel Anticancer Target for the Marine Natural Product Plitidepsin

@article{Losada2016TranslationEF,
  title={Translation Elongation Factor eEF1A2 is a Novel Anticancer Target for the Marine Natural Product Plitidepsin},
  author={A. Losada and M. Mu{\~n}oz-Alonso and Carolina Garc{\'i}a and P. A. S{\'a}nchez-Murcia and J. F. Mart{\'i}nez-Leal and J. Domínguez and M. Lillo and F. Gago and C. Galmarini},
  journal={Scientific Reports},
  year={2016},
  volume={6}
}
eEF1A2 is one of the isoforms of the alpha subunit of the eukaryotic Elongation Factor 1. It is overexpressed in human tumors and is endowed with oncogenic properties, favoring tumor cell proliferation while inhibiting apoptosis. We demonstrate that plitidepsin, an antitumor agent of marine origin that has successfully completed a phase-III clinical trial for multiple myeloma, exerts its antitumor activity by targeting eEF1A2. The drug interacts with eEF1A2 with a KD of 80 nM and a target… Expand
Binding of eEF1A2 to the RNA-dependent protein kinase PKR modulates its activity and promotes tumour cell survival
TLDR
It is uncovered that double-stranded RNA-activated protein kinase (PKR) is a novel eEF1A2-interacting partner whose pro-apoptotic effect is hindered by the translation factor, most likely through sequestration and inhibition of its kinase activity. Expand
Structural rationale for the cross-resistance of tumor cells bearing the A399V variant of elongation factor eEF1A1 to the structurally unrelated didemnin B, ternatin, nannocystin A and ansatrienin B
TLDR
Molecular models in atomic detail are presented that provide a common structural basis for the high-affinity binding of didemnin B, ternatin, ansatrienin B and nannocystin A to eEF1A1, as well as a rationale based on molecular dynamics results that accounts for the deleterious effect of replacing alanine 399 with valine. Expand
Dimethylation of eEF1A at Lysine 55 Plays a Key Role in the Regulation of eEF1A2 on Malignant Cell Functions of Acute Myeloid Leukemia
TLDR
Eukaryotic translation elongation factor 1 alpha 2 and its dimethylated product may serve as therapeutic targets, and these findings may provide support for exploring novel strategies in acute myeloid leukemia treatment. Expand
EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-β/SMAD signalling
TLDR
Findings indicate that EEF1A2 represents a promising target in the treatment of aggressive LUAD and mediates the epithelial–mesenchymal transformation (EMT) to promote the metastasis of LUAD cells in vitro and in vivo. Expand
Natural products targeting the elongation phase of eukaryotic protein biosynthesis.
TLDR
The therapeutic use of the first natural products that reached market approval, plitidepsin (Aplidin®) and homoharringtonine (Synribo®), will be introduced and two other potential indications for translation elongation inhibitors are highlighted, i.e. viral infections and genetic disorders caused by premature termination of translation. Expand
eEF1A1 Overexpression Enhances Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma
TLDR
The data indicated that eEF1A1 expression was elevated in HCC cell lines and clinical samples at both the mRNA and protein levels, and multivariate analysis indicated eEF 1A1 as an independent predictor for overall and disease-free survival. Expand
Generation of endoplasmic reticulum stress and inhibition of autophagy by plitidepsin induces proteotoxic apoptosis in cancer cells.
TLDR
It is revealed that PLD induces an increase in the levels of misfolded proteins while simultaneously inhibiting the autophagic flux, which combined prevent PLD-treated cells from reducing proteotoxic stress and lead to apoptosis. Expand
A Quick Guide to Small-Molecule Inhibitors of Eukaryotic Protein Synthesis
TLDR
Well-studied and less known inhibitors of eukaryotic protein synthesis (with the exception of mitochondrial and plastid translation) classified by their targets are reviewed and briefly described the action mechanisms of these compounds. Expand
A large scale proteome analysis of the gefitinib primary resistance overcome by KDAC inhibition in KRAS mutated adenocarcinoma cells overexpressing amphiregulin.
TLDR
New insights into proteome regulations are provided in the context of overcoming the NSCLC resistance to gefitinib through KDACi in H358 KRAS mutated and amphiregulin-overexpressingNSCLC cells. Expand
Effect of activation of the Akt/mTOR signaling pathway by EEF1A2 on the biological behavior of osteosarcoma.
TLDR
There is high expression of EEF1A2 in OS, which can promote the proliferation, migration, and invasion of OS cells in vitro and the growth of OS tumors in vivo via activation of the Akt/mTOR signaling pathway. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 54 REFERENCES
Abstract 5467: Role of the eukaryotic elongation factor eEF1A in the mechanism of action of Aplidin
TLDR
It is observed that Aplidin treatment of tumor cells and subsequent digestion of the cellular extracts with different proteases, resulted in a significant increase in the stabililty of eEF1A against protease digestion, suggesting a direct effect of APLidin on this protein. Expand
The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections
TLDR
It is indicated that eEF1A proteins play a critical role in numerous human diseases through enhancement of oncogenesis, blockade of apoptosis, and increased viral pathogenesis. Expand
Structural basis for the binding of didemnins to human elongation factor eEF1A and rationale for the potent antitumor activity of these marine natural products.
TLDR
It is suggested that the p-methoxyphenyl ring of these cyclic depsipeptides is inserted into the same pocket in eEF1A that normally lodges either the 3' terminal adenine of aminoacylated tRNA, as inferred from two prokaryotic EF-Tu, or the aromatic side chain of Phe/Tyr-163 from the nucleotide exchange factor e EF1Balpha. Expand
A2 isoform of mammalian translation factor eEF1A displays increased tyrosine phosphorylation and ability to interact with different signalling molecules
TLDR
A higher level of tyrosine phosphorylation of e EF1A2 as compared to eEF1A1 was demonstrated in several independent experiments and its importance for interaction of eEF 1A2 with Shp2 in vitro was revealed. Expand
Mouse translation elongation factor eEF1A‐2 interacts with Prdx‐I to protect cells against apoptotic death induced by oxidative stress
TLDR
The results suggest that eEF1A‐2 interacts with Prdx‐I to functionally provide cells with extraordinary resistance to oxidative stress‐induced cell death. Expand
Nannocystin A: an Elongation Factor 1 Inhibitor from Myxobacteria with Differential Anti-Cancer Properties.
TLDR
Biochemical and genetic evidence support an overlapping binding site of 1 with the anti-cancer compound didemnin B on EF-1α, and this myxobacterial chemotype offers an interesting starting point for further investigations of the potential of therapeutics targeting elongation factor 1. Expand
Eukaryotic Elongation Factor 1A Interacts with Sphingosine Kinase and Directly Enhances Its Catalytic Activity*
TLDR
This study has established a novel mechanism of regulation of both SK1 and SK2 that is mediated by their interaction with eEF1A, and shows that e EF1A is able to directly increase the activity of SK1and SK2 ∼3-fold in vitro. Expand
Eef1a2 Promotes Cell Growth, Inhibits Apoptosis and Activates JAK/STAT and AKT Signaling in Mouse Plasmacytomas
TLDR
EEF1A2 may play contribute to the induction or progression of some PCT and a small percentage of MM, and could also prove to be a useful new marker for a subset of MM and a possible target for therapy. Expand
Mechanism of protein synthesis inhibition by didemnin B in vitro.
TLDR
It is suggested that didemnin B prevents translocation by stabilizing aminoacyl-tRNA bound to the ribosomal A-site, similar to the antibiotic kirromycin, and consistent with the known affinity of didemnins for elongation factor eEF-1 alpha. Expand
Mapping the human translation elongation factor eEF1H complex using the yeast two-hybrid system.
TLDR
The human eEF1H complex is for the first time mapped using the yeast two-hybrid system, which is a powerful in vivo technique for analysing protein-protein interactions. Expand
...
1
2
3
4
5
...